Medicine shortages in the UK - why do they keep happening?

Medicine shortages in the UK remain a persistent challenge, impacting patient care and burdening pharmacy workflows. Despite advances in healthcare IT and supply chain management, including the rise of electronic prescribing and automation in dispensing, shortages continue to disrupt availability, especially of critical medications.

In this post, we will explore why medicine shortages occur in the UK, focusing on key supply chain dynamics involving single source ingredients, logistics disruption, and the evolving tools like electronic transmission of prescriptions and dispensing workflow integration that both help and sometimes complicate demand forecasting and stock management.

Understanding the context: What triggers medicine shortages in the UK?

Medicine shortages can stem from multiple factors, often overlapping. Here's a quick snapshot of the core reasons:

Supply chain concentration: Many medicines rely on single source ingredients or sole manufacturers, making them vulnerable to production glitches.
Regulatory and quality control delays: Strict MHRA approvals and GMP compliance pauses can halt batches unexpectedly.
Logistics disruption: Transport strikes, customs delays post-Brexit, and raw material scarcity delay delivery schedules.
Demand forecasting inaccuracies: Lack of coordinated data on prescriptions and usage leads to mismatched supply orders.
Pricing and contractual factors: Low reimbursement can make some medicines commercially unattractive to suppliers.

The evolving role of electronic transmission of prescriptions

The UK has made significant strides in transitioning from paper prescriptions to electronic prescribing (e-prescribing) systems.

How e-prescribing helps

Immediate data capture: Prescriptions are transmitted in real-time from GP surgeries to pharmacies, reducing transcription errors and prescription processing time.
Nomination of pharmacies: Patients often nominate a preferred pharmacy electronically, which allows better demand visibility at the dispensing location.
Repeat prescribing automation: Systems can schedule and predict when repeat prescriptions will be needed, enabling better stock planning.

These aspects can improve demand forecasting accuracy because pharmacies can anticipate incoming prescription volumes more precisely. However, the system's potential is hampered by:

Variable adoption rates across GP practices and pharmacies.
Limited integration between prescribing data and central procurement or wholesaler systems.

What regulatory requirements are satisfied?

E-prescribing inherently satisfies the MHRA’s need for accurate dispensing records, and the GPhC regulations requiring safe and accountable handling of prescriptions. Because every e-prescription has a digital audit trail, it streamlines compliance.

Dispensing workflow integration and robotic dispensing

Dispensing workflows in UK pharmacies are evolving with software integrations and automation tools:

Workflow software integration consolidates various stages: prescription reception, validation, picking, labelling, and dispensing.
Robotic dispensing systems assist by automating the physical picking of medicines, reducing human error and improving throughput.
Barcode traceability is used at multiple points in the chain, satisfying legal requirements for verifying the correct medicine, batch number, and expiry dates.

These innovations increase efficiency and patient safety but do not fully solve medicine shortages. Indeed, the businesscomputingworld.co.uk high accuracy and traceability required expose shortages more clearly and limit workarounds previously employed in paper-based systems.

Nominating pharmacies and forecasting demand

One subtle but critical factor is how patients nominate pharmacies for their prescriptions. E-prescribing depends on known dispensing points, but if nominations change frequently or data on patient movement is incomplete, demand forecasting is inaccurate.

For example, a patient might nominate one pharmacy but then visit another if the first is out of stock, creating "phantom demand" where the system expects stock at the nominated location but the actual dispensing occurs elsewhere.

Forward-looking systems attempt to incorporate aggregated prescription data to model demand on a regional basis but are still challenged by gaps in real-time stock visibility and patient behaviour unpredictability.

Repeat dispensing scheduling and its impact

Repeat dispensing, where patients collect regular supplies over weeks or months, ostensibly aids supply planning through predictable usage patterns. E-prescribing systems schedule repeat prescription authorisations, theoretically aligning manufacturing and distribution schedules.

However, several issues arise:

Patients sometimes do not collect medicines regularly, affecting real demand.
Changing clinical conditions lead to frequent adjustments in dosing or medicine choice.
Stock allocated based on repeat schedules may remain unused, artificially inflating perceived demand in some locations.

These discrepancies reduce the accuracy of procurement forecasts and cause wastage or shortages.

Interplay between logistics disruption and single source ingredients

Medicines containing single source ingredients are particularly vulnerable to external shocks. When a key supplier faces delays due to raw material scarcity or quality failures, the ripple effect causes shortages.

The UK’s reliance on global supply chains means events like:

Port congestion
Transport strikes
Regulatory inspections or border checks

can amplify delays. During Brexit transitions and the COVID-19 pandemic, these factors revealed systemic fragilities.

Summary of factors driving medicine shortages

Factor Description Example Regulatory or Workflow Impact Single source ingredients Dependence on one supplier or manufacturer Aciclovir shortage due to raw material delay Regulatory holds if GMP breach identified Logistics disruption Transport or customs delays Delayed deliveries during port strikes Stock expiry dates compressed by delay Inaccurate demand forecasting Mismatch between prescription intention and dispensing Patient switches pharmacy, stock misallocated Pharmacy records must comply with GPhC traceability rules Repeat dispensing scheduling Variability in refill behaviour Unused stock stockpiled based on repeat scripts Workflow integration systems attempt to adjust dynamically E-prescribing adoption gaps Partial digital integration leading to data silos Paper prescription re-introduced occasionally Regulators require audit trail regardless of format

What can be done to improve the situation?

The combination of technology and policy focus holds promise:

Enhance data integration: Link e-prescribing data with wholesaler and manufacturer stock systems for real-time visibility.
Improve patient nomination stability: Encourage patients to maintain pharmacy nominations to reduce phantom demand.
Expand use of dispensing workflow software: Use predictive analytics based on dispensing trends, with input from robotic dispensing systems.
Mitigate single source dependencies: Foster local or multiple suppliers to diversify risk.
Collaborate on contingency planning: MHRA, NHS, and supply chain partners should align on demand surges and supply interruptions.

Conclusion

Medicine shortages in the UK are complex phenomena rooted in supply chain fragility, logistical challenges, and evolving prescribing and dispensing practices. Electronic transmission of prescriptions and dispensing workflow integration are powerful tools for forecasting and managing stock but are not silver bullets.

Understanding the regulatory context, the importance of barcode traceability, and the realities of logistics disruption reveals that shortages are seldom from a single cause. Only through coordinated efforts embracing technology, robust supply diversification, and granular data sharing can these persistent shortages be meaningfully reduced.

Next time you hear about medicine shortages in UK dispensaries, ask: what regulatory or supply chain bottleneck is causing this, and how might better integration of e-prescribing and dispensing workflows help?